50 devices · GMDN 57665
Thyroid transcription factor-1 (TTF1) IVD antibody tests detect the presence of TTF1 proteins in clinical samples, primarily used to aid in diagnosing and differentiating thyroid-related conditions, such as lung cancer metastases or thyroid tumors. These tests help clinicians assess whether a patient’s tissue or fluid sample contains TTF1 markers, supporting accurate cancer diagnosis and treatment planning.
These devices are typically in-vitro diagnostics (IVDs) regulated under strict standards to ensure reliability and safety. They are often supplied as reagents, kits, or ready-to-use solutions for laboratory use, with classification varying by jurisdiction based on risk and intended use. Always verify local regulatory requirements before use.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.